Investment Rating - The report maintains an "Accumulate" rating for the company [1] Core Views - The company has shown steady performance with a diversified layout contributing to growth in 2024 and Q1 2025, driven by recovery in consumer electronics, automotive, and dental medical sectors [5][6] - The company achieved a revenue of 4 billion CNY in 2024, a year-on-year increase of 5%, and a net profit of 600 million CNY, up 6% year-on-year [5] - In Q1 2025, the company reported a revenue of 975 million CNY, an 18% increase year-on-year, and a net profit of 136 million CNY, a 2% increase year-on-year [5] Summary by Sections Financial Performance - In 2024, the company’s revenue was 40 billion CNY, with a net profit of 6 billion CNY, while Q4 alone contributed 10.8 billion CNY in revenue [5] - The Q1 2025 results showed a revenue of 9.75 billion CNY and a net profit of 1.36 billion CNY [5] Business Segments - The electronic materials segment benefited from recovering downstream demand, with MLCC medium powder sales gradually increasing [6] - The catalytic materials segment successfully overcame technical barriers, meeting stringent vehicle emission standards, and saw rapid growth in sales due to increased demand from overseas clients [6] - The biomedical segment received EU medical device compliance certification for several products, enhancing market recognition and paving the way for accelerated promotion in Europe [6] Growth Opportunities - The company is strategically positioned in the new energy sector, launching several lithium battery additives and becoming a major supplier in the industry [7] - The LED substrate segment has strengthened its competitive edge through technological synergies, while the communication RF micro-system chip packaging business is expected to become a significant growth point [7] - The subsidiary has made strides in digital printing materials, aiming to become a leader in the Chinese market [7] Profitability and Valuation - The report adjusts the profit forecasts for 2025-2026 downwards by 20%, with expected net profits of 754 million CNY and 914 million CNY respectively, while introducing a forecast for 2027 at 1.13 billion CNY [8][9] - The company’s EPS is projected to be 0.76 CNY for 2025, 0.92 CNY for 2026, and 1.13 CNY for 2027 [8][9]

Investment Rating - The report maintains an "Accumulate" rating for the company [1] Core Views - The company has shown steady performance with a diversified layout contributing to growth in 2024 and Q1 2025, driven by recovery in sectors such as consumer electronics, automotive, and dental healthcare [5][6] - The company achieved a revenue of 4 billion CNY in 2024, a year-on-year increase of 5%, and a net profit of 600 million CNY, up 6% year-on-year [5] - In Q1 2025, the company reported a revenue of 975 million CNY, an 18% increase year-on-year, and a net profit of 136 million CNY, a 2% increase year-on-year [5] Summary by Sections Performance Overview - In Q4 2024, the company recorded a revenue of 1.08 billion CNY, a 1% increase year-on-year and a 7% increase quarter-on-quarter, with a net profit of 123 million CNY, down 4% year-on-year and 19% quarter-on-quarter [5] - The electronic materials segment benefited from recovering downstream demand, particularly in automotive electronics and AI servers, leading to a gradual increase in MLCC dielectric powder sales [6] Strategic Developments - The company has made significant advancements in catalyst materials, successfully overcoming technical barriers to meet stringent vehicle emission standards, which has led to increased demand from overseas clients [6] - In the biomedical sector, the company’s zirconia ceramic blocks and glass ceramic blocks have received compliance certification under EU medical device regulations, enhancing market recognition and paving the way for accelerated promotion in Europe [6] Financial Projections - The report adjusts the profit forecasts for 2025-2026, projecting net profits of 754 million CNY and 914 million CNY respectively, with an estimated EPS of 0.76 CNY and 0.92 CNY [8][9] - The company’s revenue is expected to grow to 4.77 billion CNY in 2025, reflecting an 18% growth rate, with a net profit growth rate of 24.72% [9][10] Valuation Metrics - The report provides a valuation with a P/E ratio of 22 for 2025, decreasing to 15 by 2027, indicating a favorable long-term outlook [12][13] - The company’s gross margin is projected to stabilize around 40% in the coming years, despite slight declines in specific segments [12]

积极布局新能源和精密陶瓷板块，拓宽未来成长空间。公司以高纯氧化铝、勃姆石为战略支点卡位新能 源赛道，陆续推出多款锂电池正极添加剂的核心辅材，成功将滴定法氧化锆微珠的应用延伸至正负极研 磨领域。公司固态电解质、制氢领域新产品均协同行业客户有序推进产品验证和应用推广。精密陶瓷板 块是公司以材料为核心，向下游延展产业链的平台，包括氧化锆、氧化铝、氮化硅、氮化铝等材料体 系，具体产品包括陶瓷轴承球、陶瓷套筒、陶瓷插芯、陶瓷基板陶瓷管壳等。公司具备"材料-工艺-器 件"三维创新体系，可以实现对高附加值赛道的精准卡位，致力于成为领先的精密陶瓷全产业链平台型 公司。国瓷赛创投资扩建陶瓷金属化项目，达产后将进入薄膜传感器、功率电源模块、IGBT 等应用领 域。 维持"强烈推荐"投资评级。预计2025-2027 年公司归母净利润分别为7.04亿、8.47 亿、10.10 亿元，EPS 分别为0.71、0.85、1.01 元，当前股价对应PE分别为24、20、16 倍，维持"强烈推荐"投资评级。 风险提示：下游需求不及预期、原材料价格上涨、新项目投产不及预期。 事件：公司发布2025年一季报，报告期内实现收入9.75亿元，同比增 ...

风险提示：在建项目进度低于预期，产品和原料价格波动。 本报告导读： 我们看好平台型企业多元产品矩阵接力，国产替代与海外拓展双轮驱动。 投资要点： 维持"增持"评 级。考虑到外部环境影响陶瓷墨水需求，以及费用端偏刚性，我们下调25-26 年EPS 至 0.77/0.93 元（原为0.88/1.04 元）,新增27 年EPS 为1.11 元。参考可比公司估值及考虑公司成长性，给予 25 年25 倍PE 估值，对应目标价为19.25 元。 公司业绩稳健增长。2024 年，公司实现营收40.47 亿元，同比+4.86%；扣非后归母净利5.81 亿元，同比 +7.05%；其中，24Q4 营收10.80 亿元，同比+0.78%，环比+6.67%。扣非后净利1.27 亿元，同 比-8.69%，环比-12.73%。25Q1 营收9.75 亿元，同比+17.94%，环比-9.76%。扣非后净利1.27 亿元，同 比+4.88%，环比-0.17%。 平台型企业多元产品矩阵接力。2024 年，电子材料、催化材料、生物医疗、新能源材料、精密陶瓷、 数码打印及其他材料营收分别同比+4.22%、+10.01%、+6.53%、+48.34 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - In 2024, the company achieved an operating income of 4.047 billion yuan, a year-on-year increase of 4.86%, and a net profit attributable to shareholders of 605 million yuan, up 6.27% year-on-year [4] - The growth in revenue is attributed to the electronic materials sector ramping up production, significant cost reductions in the new energy sector, and steady growth in the catalyst, biomedical, and ceramics sectors [5] - The company expects net profits for 2025-2027 to be 800 million, 914 million, and 1.161 billion yuan respectively, with year-on-year growth rates of 32.2%, 14.3%, and 26.9% [8] Financial Performance Summary - In Q4 2024, the company reported an operating income of 1.08 billion yuan, a year-on-year increase of 0.78% and a quarter-on-quarter increase of 6.67% [4] - The net profit for Q4 2024 was 123 million yuan, down 4.44% year-on-year and 19.25% quarter-on-quarter [4] - The company’s revenue and net profit projections for 2025-2027 indicate a positive growth trajectory, with operating income expected to reach 6.505 billion yuan by 2027 [9] Business Segment Performance - The electronic materials segment is experiencing a recovery, with MLCC powder entering a growth phase and new products achieving significant market penetration [5] - The catalyst materials segment is advancing with new technologies to meet stringent emission standards, while the biomedical materials segment is enhancing its manufacturing capabilities [5] - The new energy materials segment saw a remarkable 110.74% year-on-year increase in product sales due to cost reductions [5] Growth Drivers - Subsidiaries like Kanglitai and Saichuang are introducing innovative products and enhancing manufacturing processes, contributing to new growth avenues for the company [6] - The company is establishing itself as a leading global producer of ceramic inks through strategic projects and partnerships [7]